A Randomized, Multicenter, Open-Label, Parallel-Group Clinical Study Comparing the Safety and Efficacy of MYL-1601D with NovoLog® in Type 1 Diabetes Mellitus Patients
Location: PAMF (Peninsula and South Bay)
Please contact Elizabeth Jameiro Jameire@sutterhealth.org about study Mylan’s Insulin Aspart
Culturally Adapted DPP [Diabetes Prevention Program] Intervention for Mexican Americans in Primary Care: An RCT [randomized controlled trial]
Investigator: Kristen M.J. Azar, R.N., BSN, MSN/MPH
Investigator: Cheryl Stults, Ph.D.